Skip to main content

Advertisement

Table 3 Demographic characteristics and comorbidity status of the Matched hdPS Sub-Cohort at baseline

From: Head to head comparison of the propensity score and the high-dimensional propensity score matching methods

  Low potency n (%) High potency n (%) Absolute standardized differences
  116,014 (100.0) 116,014 (100.0)  
Age, mean (SD)a 64.6 (11.2) 64.6 (11.2) 0.002
Male sex 58,194 (50.2) 58,494 (50.4) 0.005
At least 5 medical outpatient visits 66,453 (57.3) 66,390 (57.2) 0.001
At least 1 hospitalisation 28,265 (24.4) 28,604 (24.7) 0.007
Myocardial infarction 7558 (6.5) 7995 (6.9) 0.015
Stroke 3620 (3.1) 3897 (3.4) 0.013
Hypertension 48,268 (41.6) 48,474 (41.8) 0.004
Hypercholesterolemia 37,486 (32.3) 37,841 (32.6) 0.007
Peripheral vascular disease 2293 (2.0) 2671 (2.3) 0.023
Congestive heart failure 5198 (4.5) 5479 (4.7) 0.012
Coronary artery bypass graft 1670 (1.4) 1661 (1.4) 0.001
Percutaneous coronary intervention 4590 (4.0) 4846 (4.2) 0.011
Dispensation of loop diuretics 7139 (6.2) 7256 (6.3) 0.004
Dispensation of calcium blockers 26,510 (22.9) 26,716 (23.0) 0.004
Dispensation of beta-blockers 33,901 (29.2) 34,389 (29.6) 0.009
Dispensation of angiotensin receptor blockers 20,345 (17.5) 20,876 (18.0) 0.012
Dispensation of angiotensin converting enzyme inhibitors 24,472 (21.1) 25,289 (21.8) 0.017
At least 5 different drugs dispensed 66,600 (57.4) 66,820 (57.6) 0.004
  1. Comorbidity status, drug dispensations and medical utilization rates were assessed in the year prior to the cohort entry date. Absolute standardized differences are defined as the between group difference over the pooled standard deviation of the two groups
  2. aAt the cohort entry date